化剂和ERCC1-XPF抑制剂之间的协同作用是p53依赖的
Gloria Ciniero1,2, Tiago Marques Pedro2, Charles Dumontet2
1PolitoBIOMedLab, Department of Mechanical and Aerospace Engineering, Politecnico di Torino, Turin, Italy.
Fundamental & clinical pharmacology
|November 9, 2024
概括
这项研究描述了向DNA修复蛋白ERCC1和XPF的抑制剂. 该抑制剂增强了化疗的疗效,特别是在野生型p53瘤中,为癌症治疗提供了新的策略.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 基因组稳定性 基因组稳定性
背景情况:
- DNA 修复对基因组稳定至关重要,但可以通过消除药物诱导的 DNA 损伤来降低化疗的有效性.
- 抑制DNA修复是一种有希望的策略,可以提高癌症患者的化疗疗效.
研究的目的:
- 为了进一步描述针对ERCC1-XPF相互作用的抑制剂,核酸切除修复中的关键蛋白质.
- 为了评估抑制剂与基化疗的协同效应.
主要方法:
- 在共同化研究中利用了各种细胞系.
- 评估细胞存活率和DNA修复能力.
- 研究了ERCC1,XPF和p53表达在药物反应中的作用.
主要成果:
- ERCC1-XPF抑制剂与衍生物的协同作用超过了之前报告的.
- 缺乏ERCC1或XPF表达的细胞中没有协同作用.
- 强化药物活性仅在表达野生类型p53.3的细胞中观察到.
结论:
- 证实了ERCC1-XPF抑制剂的作用机制.
- 提供了支持使用该抑制剂来增强现有癌症疗法的额外数据.
- 突出了ERCC1,XPF和p53状态在预测治疗反应中的重要性.
相关概念视频
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
DNA Damage can Stall the Cell Cycle
9.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.0K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Nucleotide Excision Repair
3.4K
DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
3.4K
The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


